source
- NIH Scales Back Replication Initiative, Critics Warn It Undermines Scientific RigorNIH originally announced a push to make replication a core part of biomedical research, including an $850,000 Replication Prize launched in March 2025. Health secretary Robert F. Kennedy Jr. sugge…
- Treasury expected to be harder on China biotech deals in new rulesThe pharma industry is bracing for a more stringent assessment of China deals from the Treasury Department, despite months of work to escape a harsh clampdown on buying new assets there. Endpoints…Endpoints · 21m ago↗ source
- Rapport Therapeutics' epilepsy drug RAP-219 meets primary endpoint in bipolar mania Phase II trial